Amyloidosis, protein conformation dynamics and neurological diseases;AMYLOSE, DYNAMIQUE CONFORMATIONNELLE DES PROTEINES ET MALADIES NEUROLOGIQUES

Revue Neurologique

Volumn 152, Issue 3, 1996, Pages 153-157

  Tranchant, C ^a   Kodier, G ^a   Schmitthaeusler, R ^b   Warter, J M ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Lab Francais Fractionnement B   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYLOIDOSIS; CHEMICAL STRUCTURE; HUMAN; PRION DISEASE; SHORT SURVEY; CHEMISTRY; GENETICS; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRION; PROTEIN CONFORMATION; REVIEW;

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOIDOSIS; HUMANS; NERVOUS SYSTEM DISEASES; PRION DISEASES; PRIONS; PROTEIN CONFORMATION;

EID: 0030097451     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (26)

1. BAKER H.F., RIDLEY R.M., DUCHEN L.W., CROW T.J., BRUTON C.J. (1994). Induction of β(A4)-Amyloid in primates by injection of Alzheimer's disease brain homogenate. Molecular Neurobiology, 8 : 25-39.
2. BÜLER H., AGUZZI A., SAJLER A., GREINER R.A., AUTENRIED P., AGUET M., WEISSMANN C. (1993). Mice devoid of PrP are resistant to scrapie. Cell. 73 : 1339-1347.
3. DEARMOND S.J., PRUSINER S.B. (1993). The neurochemistry of Prion disease. J Neurochem; 61 : 1589-1601.
4. FORLONI G., ANGERETTI N., CHIESA R., MONZANI E., SALMONA M., BUGIANI O., TAGLIAVINI F. (1993). Neurotoxicity of a prion protein fragment. Mature, 362 : 543-543.
5. HENSLEY K., CARNEY J.M., MATTSON M.P., AKSENOVA M., HARRIS M., WU J.F., FLOYD R.A., BUTTERFIELD D.A. (1994). A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide : relevance to Alzheimer disease. Proc Natl Acad Sci, 91 : 3270-3274.
6. JARRET J.T., LANSBURY P.T. (1993). Seeding « one-dimensional crystallization » of amyloid : a pathogenic mechanism in Alzheimer's disease and scrapie ? Cell, 73 : 1055-1058.
7. KINGSTON I.B., CASTRO M.J.M., ANDERSON S. (1995). In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid β-peptide analogues. Nature Medicine, 1 : 138-142.
8. KIRSCHER D.A., ABRAHAM C., SELKOE D.J. (1986). X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-β conformation. Proc Natl Acad Sci, 83 : 503-507.
9. KOCISKO D.A., COME J.H., PRIOLA S.A., CHESEBRO B., RAYMOND G.J., LANSBURY P.T., CAUGHEY B. (1994). Cell-free formation of proteaseresistant prion protein. Nature, 370 : 471-474.
10. LA FERLA F.M., TINKLE B.T., BIEBERICH C.J., HAUDENSCHILD C.C., JAY G. (1995). The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genetics, 9 : 21-29.
11. LIAUTARD J.P. (1991). Are prions misfolded molecular chaperones ? FEBS, 294 : 155-157.
12. MA J., YEE A., BREWER H.B., DAS S., POTTER H. (1994). Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature, 372 : 92-94.
13. MEDORI R., TRITSCHLER H.J. (1993). Prion protein gene analylis in three kindreds with fatal familial insomnia (FFI) : codon 178 mutation and codon 129 polymorphism. Am J Hum Genet, 53 : 822-827.
14. MEYER R.K., MCKINLEY M.P., BOWMAN K.A., BRAUNFELD M.B., BARRY R.A., PRUSINER S.B. (1986). Separation and properties of cellular and scrapie prion proteins Proc Natl Acad Sci, 88 : 2310-2314.
15. MONARI L., CHEN S.G., BROWN P., PARCHI P., PETERSEN R.B., MIKOL J., GRAY F., CORTELLI P., MONTAGNA P., GHETTI B., GOLDFARB L.V., GAJDUSEK D.C., LUGARESI E., GAMBETTI P., AUTILIO-GAMBETTI L. (1994). Fatal familial insomnia and familial Creutzfeldt-Jakob disease : different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci, 91 : 2839-2842.
16. PAN K.M., BALDWIN M., NGUYEN J., GASSET M., SERBAN A., GROTH D., MEHLHORN I., HUANG Z., FLETTERICK R.J., COHEN F.E., PRUSINER S.B. (1993). Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci, 90 : 10962-10966.
17. PALMER M.S., DRYDEN A J., HUGHES J.T., COLUNGE J. (1991). Homozygous prion protein genotype predisposes to spradic CreutzfeldtJakob disease. Nature, 352 : 340-342.
18. PIKE C.J., WALENCEWICZ-WASSERMAN A.J., KOSMOSKI J., CRIBBS D.H., GKABE C.G., COTMAN C.W.H (1995). Structure-activity analyses of β-amyloid peptides : contributions of the β 25-35 region to aggregation and neurotoxicity. J Neurochem, 64 : 253-265.
19. PRICE D.L., BORCHELT D.R., SISODIA S.S. (1993). Alzheimer disease and the prion disorders amyloid β-protein and prion protein amyloidosis. Proc Natl Acad Sci, 90 : 6381-6384.
20. PRUSINER S. (1982). Novel proteinaceous infectious particles cause scrapie. Science, 216 : 136-144.
21. PRUSINER S. (1990). Novel structure and genetics of prions causing neurodegeneration in humans and animals. Biologicals, 18 : 247-262.
22. ROHER A.E., LOWENSON J.D., CLARKE S., WOODS A.S., COTTER R.J., GOWING E., BALL M.J. (1993). β-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits : implications for the pathology of Alzheimer disease. Proc Natl Acad Sci, 90 : 10836-10840.
23. ROHWER R.G. (1992) Alzheimer's disease transmission : possible artefact due to intercurrent illness. Neurology, 42 : 287-288.
24. SIMMONS L.K., MAY P.C., TOMASELLI K.J., RYDEL R.E., FUSON K.S., BRIGHAM F.E., WRIGHT S., LIEBERBURG I., BECKER G.W., BREMS D.N., LI W.Y. (1994). Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Molecular Pharmacology, 45 : 373-379.
25. SOTO C., BRANES M.C., ALVAREZ J., LNESTROSA N.C.H (1994). Structural determinants of the Alzheimer's amyloid β-peptide. J Neurochem, 63 : 1191-1198.
26. TAGLIAVINI F., PRELLI F., VERGA L., GIACCONE G., SARMA R., GOREVIC P., GHETTI B., PASSERINI F., GHIBAUDI E., FORLONI G., SALMONA M., BUGIANI O., FRANGIONE B. (1993). Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci, 90 : 9678-9682.